Reducing the pressure in pulmonary arterial hypertension: sotatercept, haemodynamics and the right ventricle
- PMID: 37696566
- DOI: 10.1183/13993003.01513-2023
Reducing the pressure in pulmonary arterial hypertension: sotatercept, haemodynamics and the right ventricle
Conflict of interest statement
Conflict of interest: L.C. Price and C. McCabe have no relevant conflicts of interest related to this work. J. Weatherald reports grants or contracts paid to his institution from AstraZeneca, Bayer, Janssen and Merck, consulting fees and honoraria from Janssen and Merck, payment for expert testimony from Sprigings Intellectual Property Law, travel support from Janssen, participation on a data safety and monitoring board or advisory board for Janssen, Acceleron and the Université de Laval, and has an unpaid leadership role at the Pulmonary Hypertension Association of Canada.
Comment on
-
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.Eur Respir J. 2023 Sep 21;62(3):2301107. doi: 10.1183/13993003.01107-2023. Print 2023 Sep. Eur Respir J. 2023. PMID: 37696565 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources